The first case reports involving Propionimicrobium lymphophilum, a rarely encountered anaerobic Gram-positive non-sporeforming rod, are presented here as urinary tract infections. Initial detection of these bacteria required urine Gram stains. Comparison of the type strain to the two isolates by various methods is depicted and includes antimicrobial susceptibility data.
phology, including club-shaped and coccoid forms. The growth was subcultured to CDC-ANA for analysis via the RapID ANA II system (Thermo Fisher/Remel). Microcode 000671 resulted, indicating a 99.8% probability of Clostridium hastiforme with a probability level of "implicit." The isolate lacked both colony characteristics and any microscopic resemblance to Clostridium species. A report of "Ͼ10 5 CFU/ml anaerobic Gram-positive rod, nonsporeformer; resembles Actinomyces species" was released. The significance of finding a Gram-positive rod in urine was questioned. The patient was not treated at this time but was referred to urology.
At his urology appointment 2 weeks later, the patient indicated sharp pain upon urination with increased frequency. A renal and bladder ultrasound performed prior to the appointment failed to disclose any kidney or bladder stones. Another urine sample was collected to verify previous unusual culture results. The urologist prescribed ciprofloxacin (CIP) at 500 mg every 12 h for 15 days. The sample collected tested positive for nitrite, LE, and Ͼ300 mg/dl protein. Microscopic observation revealed Ͼ50 WBC/HPF, 10 to 15 RBC/HPF, and 4ϩ bacteria. An unspun urine Gram stain displayed the same pleomorphic Gram-positive rods seen previously. Three-day growth was subcultured for RapID ANA II analysis. The results duplicated the previous specimen: growth of Ͼ10 5 CFU/ml anaerobic Gram-positive rods and a RapID ANA II microcode of 000671. Anaerobe susceptibility testing was not available at this time.
Symptoms resolved after treatment with CIP. Urinalyses were performed upon initial completion and at 2 and 4 months' posttreatment, exhibiting similar results. Urine dipstick testing was negative, with the exception of 30 mg/dl protein. The microscopic examinations confirmed 0 to 3 WBC/HPF and 0 to 5 RBC/HPF. Bacteria were reported as "none observed" in each case.
The final isolate in this case, designated NH-212, was sent to reference labs for identification: MIDI Labs, Inc., in Newark, DE, for partial 16S rRNA gene sequencing and the Culture Collection University of Gotëborg, Gotëborg, Sweden (CCUG). The CCUG reported an identification of Propionimicrobium lymphophilum after extensive phenotypic testing that included cellular fatty acidfatty acid methyl ester (CFA-FAME) analysis and reactions from RID32S, ID32AN, and Coryne API test strips (bioMérieux, Marcy l'Etoile, France). The CCUG did not use the API strips to obtain identification from each strip separately. API test result reactions were combined with classical in-house tests and utilized their own huge database and software for identification. NH-212 was assigned the number CCUG 54740. The partial (approximately 500-bp) 16S gene sequencing at MIDI Labs was performed using universal primers at positions 0005F and 0531R. The region was PCR amplified and sequenced using DNA polymerase (Taq polymerase) and dye terminator chemistry. The samples were electrophoresed on an ABI Prism 3130xl genetic analyzer (Life Technologies, Carlsbad, CA). After a GenBank search with the Basic Local Alignment Search Tool (BLAST), the sequence identified a 99% match with "Propionibacterium lymphophilum" (GenBank accession no. AJ003056), now known as Propionimicrobium lymphophilum.
Case 2. A 70-year-old extremely ill male was evaluated in urgent care. The patient had exhibited dramatic weight loss and a frequent, productive cough accompanied by brown sputum. He claimed to have not been evaluated by a doctor in many years. His urine sample was positive for LE and for nitrite and had 10 to 15 WBC/HPF and 4ϩ bacteria. An unspun urine Gram stain detected clumps of Gram-positive rods. Due to suprapubic tenderness and painful urination, the physician prescribed ciprofloxacin (CIP) at 250 mg twice daily for 7 days. The physician referred him for further evaluation for his ominous-looking chest X rays and recent weight loss. Urinary symptoms abated within 2 days after commencement of treatment. After 3 days, the original urine culture revealed growth only under anaerobic incubation conditions on blood agar and CDC-ANA. The growth of the small colonies of pleomorphic, Gram-positive rods indicated urine numbers of Ͼ10 5 CFU/ml. The patient was lost to follow-up due to home hospice care admission. He died less than 2 months later of metastatic lung cancer.
This isolate was designated NH-1513. The same two reference laboratories were utilized as for the case 1 isolate. It was identified as Propionimicrobium lymphophilum by both MIDI Labs via partial 16S rRNA gene sequencing and by the CCUG using their phenotypic analysis methods (www.ccug.se). It was assigned the number CCUG 48580. Both methods of identification were as described for case 1.
Basic clinical laboratory procedures and anaerobic susceptibility testing were performed on the two patient isolates. The type strain (ATCC 27520) from the American Type Culture Collection (ATCC) in Manassas, VA, was obtained for comparison.
All three organisms grew equally well on blood agar, chocolate agar, phenylethyl alcohol blood agar (BD), Columbia CNA blood agar (BD), and CDC-ANA media. Anaerobic incubation for 4 days was performed as described in references 1, 2, and 3. Figure 1A demonstrates the growth of NH-1513 at day 4, while 
NH-1513 and ATCC 27520
T were assessed with the RapID ANA II system. Both yielded the same microcode as the case 1 isolate NH-212: 000671. Biochemical reactions are shown in Table 1. Using the RapID CB Plus (Thermo Fisher/Remel) with 6 h of incubation, analysis of NH-212 and ATCC 27520 T each produced the microcode 4024510. NH-1513 generated microcode 5024510. The only difference between the three organisms was the utilization of the glucose substrate by NH-1513. The RapID CB Plus is not intended for identification of anaerobic Gram-positive bacilli. In this case, the microcodes proved valuable for comparison of the clinical isolates and the type strain.
The RapID ANA II does not include nitrate. The RapID CB Plus produced negative nitrite results. The urine samples from the two patients tested positive for nitrite. The RapID systems detect preformed enzymes. Another rapid enzyme test, the nitrate disk test (Key Scientific, Stamford, TX), was performed and also negative. Using the indole-nitrate broth method (Anaerobe Systems, Morgan Hill, CA), which requires growth, nitrite tested positive for both of the clinical isolates but negative for ATCC 27520
T . Nitrate reduction is a variable characteristic of Propionimicrobium lymphophilum (3, 6) . The antimicrobial susceptibilities were determined using the Etest method (bioMérieux) for benzylpenicillin, ceftriaxone, tetracycline, imipenem, amoxicillin-clavulanate, clindamycin, CIP, sulfamethoxazole-trimethoprim (SXT), and metronidazole. A suspension equal to a no. 1 McFarland standard according to the manufacturer's instructions for anaerobes was inoculated on brucella agar with 5% sheep blood, hemin, and vitamin K (Thermo Fisher/Remel). Clinical and Laboratory Standards Institute (CLSI) document M100-S24 under the anaerobe section was used for the antibiotic interpretive standards (7). The plates were incubated in an anaerobic atmosphere for 48 h and did not display difference at 72 h. For antibiotics whose breakpoints had not been established for anaerobes (vancomycin, SXT, and CIP), only MICs are shown in Table 2 . The three test organisms were susceptible to most antibiotics tested but resistant to metronidazole and likely SXT at Ͼ32 g/ml. It has been shown that brucella agar is not optimum for SXT anaerobic testing (8) . SXT was also tested on horse blood agar (Hardy Diagnostics, Santa Maria, CA) to confirm results. Previous reports of P. lymphophilum susceptibility data were not found for comparison.
For confirmatory identification of this rare bacterium, the full 16S rRNA gene sequencing results from the two clinical isolates and the type strain were characterized at MIDI Labs using universal primers 0005F and 1513R. Samples were prepared and analyzed in the same manner as the partial sequencing and electrophoresed on an ABI Prism 3130 genetic analyzer (Life Technologies). Consensus sequences of the approximately 1,480-bp regions were compared to sequences in the Sherlock DNA Library MD16M2 version 2.22, which failed to produce a match. Sequence data for the three test organisms compared to the GenBank database by BLAST search matched each organism to Propionimicrobium lymphophilum (GenBank accession no. NR_114337) with 99% similarity. Samples NH-1513 and NH-212 had identical sequences with only a 2-base difference from ATCC 27520
T . The sequence alignment, or total difference, was 0.13%. To meet the requirements for species identification for Grampositive anaerobes, as described in CLSI document MM18-A (9), the GenBank BLAST search was continued for both clinical isolates. This revealed 99% similarity to Propionimicrobium lymphophilum strain JCM 5829 and Propionimicrobium lymphophilum strain DSM 4903, the type strain (DSM 4903 ϭ ATCC 27520). Brooklawnia cerclae strain BL34
T was the next closest match at 94% similarity. Brooklawnia spp. and Propionimicrobium spp. are members of the same family, Propionibacteriaceae. The next type strain encountered in the search was Propionibacterium propionicum DSM 43307, with 93% similarity. The ezTaxon database (http://www.ezbiocloud.net/eztaxon) for the sequences of the clinical isolates showed 99.9% identity to the type strain DSM 4903 for both isolates. The next closest match was Propionibacterium propionicum F0230a at 92.6% identity. The closest type strain was Granulicoccus phenolivorans DSM 17626 at 92.0% identity.
Propionimicrobium was proposed as a genus in the family Propionibacteriaceae in 2002, with a single species, Propionimicrobium lymphophilum (3). The authors described various name changes, including "Corynebacterium lymphophilum," and "Propionibacterium lymphophilum." The original work was accomplished in 1916 by Torrey, who described bacteria isolated from lymph nodes of patients with Hodgkin's disease, calling them "Bacillus lymphophilus" (5) .
Diseases caused by Propionimicrobium lymphophilum are not well established. A literature search including all of its previous names did not reveal any published case reports. However, isolates from human sources are listed on the CCUG website (www.ccug .se; 2014) and include three from human blood. Other examples of isolate sources can be found in The Prokaryotes (10) . The type strain ATCC 27520 originates from submaxillary tissue (www.atcc .org). Imirzalioglu et al. examined a large number of urine cultures by nucleic acid-based methods, directly detecting P. lymphophilum in an unspecified number of culture-negative, LE-positive urine specimens (11) .
Successful treatment was achieved with CIP in both cases. Al- 
Glycine-␤-naphthylamide GLY ϩ 13
Proline though CIP is not active against many anaerobes (12) , the MICs here were only 0.75 g/ml. One of the most common anaerobes isolated from human infections, Propionibacterium acnes, is well known for being susceptible to CIP (13, 14) . Propionibacterium spp. belong to the same family as Propionimicrobium, the Propionibacteriaceae.
In conclusion, the first two case reports of P. lymphophilum infections have been presented here. With the increasing availability of new technologies, the frequency and spectrum of infections as well as the ecology of this bacterium may be clarified. Initial detection of P. lymphophilum in urine specimens will remain a problem due to the need for direct Gram staining of the specimen and nonstandard growth conditions.
